116 related articles for article (PubMed ID: 36216654)
1. Retraction notice to "Long non-coding RNA LINC00160 functions as a decoy of microRNA-132 to mediate autophagy and drug resistance in hepatocellular carcinoma via inhibition of PIK3R3" [Canc. Lett. 478 (2020) 22-33].
Zhang W; Liu Y; Fu Y; Han W; Xu H; Wen L; Deng Y; Li K
Cancer Lett; 2022 Nov; 549():215933. PubMed ID: 36216654
[No Abstract] [Full Text] [Related]
2. MiR-513b-5p represses autophagy during the malignant progression of hepatocellular carcinoma by targeting PIK3R3.
Jin W; Liang Y; Li S; Lin G; Liang H; Zhang Z; Zhang W; Nie R
Aging (Albany NY); 2021 Jun; 13(12):16072-16087. PubMed ID: 34120890
[TBL] [Abstract][Full Text] [Related]
3. Retraction notice to "MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5" [Canc. Lett. 322 (2012) 148-158].
Xu XM; Wang XB; Chen MM; Liu T; Li YX; Jia WH; Liu M; Li X; Tang H
Cancer Lett; 2021 Oct; 517():105. PubMed ID: 34274168
[TBL] [Abstract][Full Text] [Related]
4. Retraction Notice to: Silencing Long Non-coding RNA LINC01224 Inhibits Hepatocellular Carcinoma Progression via MicroRNA-330-5p-Induced Inhibition of CHEK1.
Gong D; Feng PC; Ke XF; Kuang HL; Pan LL; Ye Q; Wu JB
Mol Ther Nucleic Acids; 2022 Jun; 28():636. PubMed ID: 35615004
[TBL] [Abstract][Full Text] [Related]
5. Retraction notice to "EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway" [Canc. Lett. 430 (2018) 97-108].
Ma Q; Zhang Y; Liang H; Zhang F; Liu F; Chen S; Hu Y; Jiang L; Hao Y; Li M; Liu Y
Cancer Lett; 2022 Nov; 549():215932. PubMed ID: 36216653
[No Abstract] [Full Text] [Related]
6. Retraction notice to " IP1867B suppresses the Insulin-like Growth Factor 1 Receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas" [Canc. Lett., 458 (2019) pages 29-38].
Mihajluk K; Simms C; Reay M; Madureira PA; Howarth A; Murray P; Nasser S; Duckworth CA; Pritchard DM; Pilkington GJ; Hill R
Cancer Lett; 2021 Jun; 507():39. PubMed ID: 33743517
[No Abstract] [Full Text] [Related]
7. Corrigendum to "Long non-coding RNA Unigene 56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells" [Canc. Lett. 382 (2016) 166-175].
Lv J; Fan HX; Zhao XP; Lv P; Fan JY; Zhang Y; Liu M; Tang H
Cancer Lett; 2020 Mar; 472():181-182. PubMed ID: 31879079
[No Abstract] [Full Text] [Related]
8. Retraction notice to "SRI36160 is a specific inhibitor of Wnt/-catenin signaling in human pancreatic and colorectal cancer cells" [Canc. Lett. 389C (2017) 41-48].
Li Y; Oliver PG; Lu W; Pathak V; Sridharan S; Augelli-Szafran CE; Buchsbaum DJ; Suto MJ
Cancer Lett; 2018 May; 422():131. PubMed ID: 29579438
[No Abstract] [Full Text] [Related]
9. Sulforaphane suppresses autophagy during the malignant progression of gastric carcinoma via activating miR-4521/PIK3R3 pathway.
Peng ZT; Gu P
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S711-S720. PubMed ID: 34749521
[TBL] [Abstract][Full Text] [Related]
10. LINC00160 mediated paclitaxel-And doxorubicin-resistance in breast cancer cells by regulating TFF3 via transcription factor C/EBPβ.
Wu H; Gu J; Zhou D; Cheng W; Wang Y; Wang Q; Wang X
J Cell Mol Med; 2020 Aug; 24(15):8589-8602. PubMed ID: 32652877
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum to "MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways" [Canc. Lett. 337 (2013) 226-236].
Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Chen J; Su C
Cancer Lett; 2020 Mar; 473():198-199. PubMed ID: 31926781
[No Abstract] [Full Text] [Related]
12. Corrigendum to "AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma" [Canc. Lett. 414 (2018) 71-80].
Wang LL; Jin XH; Cai MY; Li HG; Chen JW; Wang FW; Wang CY; Hu WW; Liu F; Xie D
Cancer Lett; 2022 Jul; 539():215700. PubMed ID: 35525812
[No Abstract] [Full Text] [Related]
13. STAT3-regulated LncRNA LINC00160 mediates cell proliferation and cell metabolism of prostate cancer cells by repressing RCAN1 expression.
Zhu W; Sheng D; Shao Y; Zhang Q; Peng Y
Mol Cell Biochem; 2022 Mar; 477(3):865-875. PubMed ID: 35067783
[TBL] [Abstract][Full Text] [Related]
14. Retraction notice to "Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer" [Canc. Lett. 434 (2018) 1-10].
Gu J; Wang Y; Wang X; Zhou D; Shao C; Zhou M; He Z
Cancer Lett; 2021 Oct; 517():106. PubMed ID: 34274167
[TBL] [Abstract][Full Text] [Related]
15. LINC00160 mediates sunitinib resistance in renal cell carcinoma via SAA1 that is implicated in STAT3 activation and compound transportation.
Cheng G; Liu Y; Liu L; Ruan H; Cao Q; Song Z; Bao L; Xu T; Xiong Z; Liu J; Liu D; Liang H; Jiang G; Yang X; Yang H; Chen K; Zhang X
Aging (Albany NY); 2020 Sep; 12(17):17459-17479. PubMed ID: 32921632
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum to "NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma" [Canc. Lett. 476 (2020) 48-56].
Leung HW; Lau EYT; Leung CON; Lei MML; Mok EHK; Ma VWS; Cho WCS; Ng IOL; Yun JP; Cai SH; Yu HJ; Ma S; Lee TKW
Cancer Lett; 2021 Feb; 499():2. PubMed ID: 32563702
[No Abstract] [Full Text] [Related]
17. Retraction notice to "Differential effects of valproic acid on growth, proliferation and metastasis in HTB-5 and HTB-9 bladder cancer cell lines" [Canc. Lett. 281/2 (2009) 196-202].
Byun SS; Kim FJ; Khandrika L; Kumar B; Koul S; Wilson S; Koul HK
Cancer Lett; 2021 Oct; 519():343. PubMed ID: 34429223
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA hsa_circ_0061395 accelerates hepatocellular carcinoma progression via regulation of the miR-877-5p/PIK3R3 axis.
Yu Y; Bian L; Liu R; Wang Y; Xiao X
Cancer Cell Int; 2021 Jan; 21(1):10. PubMed ID: 33407443
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-367 directly targets PIK3R3 to inhibit proliferation and invasion of oral carcinoma cells.
Sun H; Feng X
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32378714
[TBL] [Abstract][Full Text] [Related]
20. Retraction notice to "Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer" [Canc. Lett. 520 (2021) 385-399].
Taromi S; Firat E; Simonis A; Braun LM; Apostolova P; Elze M; Passlick B; Schumacher A; Lagies S; Frey A; Schmitt-Graeff A; Burger M; Schmittlutz K; Follo M; von Elverfeldt D; Zhu X; Kammerer B; Diederichs S; Duyster J; Manz MG; Niedermann G; Zeiser R
Cancer Lett; 2022 Jul; 537():215680. PubMed ID: 35461758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
